Linor Haimson

Linor Haimson has extensive experience in the pharmaceutical industry, with a focus on clinical operations and management. Linor is currently working at Clexio Biosciences as the Head of Clinical Operations and Product Leader, a position they have held since September 2023. Prior to this role, they served as the Head of Clinical Operations at Clexio Biosciences from September 2020 to September 2023. Before joining Clexio Biosciences, Linor worked at Teva Pharmaceuticals, where they held various positions including Associate Director and Head of Global Clinical Operations for Headache Studies from January 2016 to July 2018. Linor also served as a Senior Global Clinical Project Manager, CNS/Pain from March 2014 to January 2016, Head of IL Data Management from February 2012 to February 2014, and Head of Clinical Quality Control from September 2008 to January 2012. Linor's career at Teva Pharmaceuticals began in September 2006 as a CQC associate, a role they held until August 2008.

Linor Haimson completed their Master of Business Administration (MBA) degree in Biotech at The College of Management Academic Studies from 2019 to 2020. Linor also holds a Master of Science (MsC) degree in Genetics from Tel Aviv University, earned between 1999 and 2001. Prior to that, their education history includes attending The Hebrew Reali School, although specific details such as degree and field of study are not provided.